Another probable explanation for these contradictory findings is that in this study population, MCP-4 might display both pro-inflammatory chemotactic activities leading to MDD development and neuroprotective functions diminishing the depressive symptoms. This evidence concerns the gene CCL13 and major depressive disorder.